Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular Predictors

Neoadjuvant Chemotherapy (NAC) in Breast Cancer (BC) has proved useful for the reduction in tumor burden prior to surgery, allowing for a more extensive breast preservation and the eradication of subjacent micrometastases. However, the impact on prognosis is highly dependent on the establishment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chica-Parrado, María Rosario, Godoy-Ortiz, Ana, Jiménez, Begoña, Ribelles, Nuria, Barragan, Isabel, Alba, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463925/
https://www.ncbi.nlm.nih.gov/pubmed/32708049
http://dx.doi.org/10.3390/cancers12082012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463925/
https://www.ncbi.nlm.nih.gov/pubmed/32708049
http://dx.doi.org/10.3390/cancers12082012

Ejemplares similares